Embolism venous and Hypersensitivity

Summary:

Hypersensitivity is found among people with Embolism venous, especially for people who are female, 60+ old.

The study analyzes which people have Hypersensitivity with Embolism venous. It is created by eHealthMe based on reports of 36 people who have Embolism venous from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Embolism venous?

Embolism venous (embolus may pass into the arterial system) is found to be associated with 306 drugs and 392 conditions by eHealthMe. Check the latest studies of Embolism venous.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,752 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 15, 2026

36 people who have Embolism Venous and Hypersensitivity are studied.

Would you have Hypersensitivity when you have Embolism venous?

Gender of people who have Embolism Venous and experienced Hypersensitivity *:

female: 60.61 %
male: 39.39 %

Age of people who have Embolism Venous and experienced Hypersensitivity *:

Common co-existing conditions for these people *:

High Blood Pressure: 7 people, 19.44%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 13.89%
Insomnia (sleeplessness): 4 people, 11.11%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 8.33%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 5.56%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.56%
Combined Immunodeficiency: 2 people, 5.56%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 5.56%
Pain: 2 people, 5.56%

Common drugs taken by these people *:

Common symptoms for these people *:

Rashes (redness): 12 people, 33.33%
Nausea (feeling of having an urge to vomit): 7 people, 19.44%
Proctalgia (pain in the rectum): 5 people, 13.89%
Salivary Gland Pain: 5 people, 13.89%
Nausea And Vomiting: 5 people, 13.89%
Insomnia (sleeplessness): 5 people, 13.89%
Pain: 5 people, 13.89%
Pain In Extremity: 5 people, 13.89%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 13.89%
Weakness: 5 people, 13.89%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Embolism venous (12,049 reports)
Hypersensitivity (272,618 reports)

All the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,752 drugs)

All the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypersensitivity and Embolism venous, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.